APOE4 Gene Triggers Early Brain Hyperactivity Before Alzheimer's Symptoms Appear
New research reveals how the APOE4 gene causes brain network dysfunction years before Alzheimer's disease symptoms develop.
Alzheimer's disease research, amyloid plaques, tau tangles, and cognitive decline
177 articles
New research reveals how the APOE4 gene causes brain network dysfunction years before Alzheimer's disease symptoms develop.
New study reveals brain blood vessel aging as key driver of memory loss, with senolytic drugs showing promise for reversal.
Comprehensive review of 2021-2025 proteomics reveals 866 consensus protein changes and novel therapeutic targets in Alzheimer's disease.
Researchers identify 25 cerebrospinal fluid proteins that better predict amyloid and tau pathology stages than current biomarkers.
Breakthrough research shows myelin damage starts years before MS symptoms, opening new possibilities for early detection and intervention.
16-week ketogenic diet study shows sex-specific microbiome and brain metabolite changes in APOE4 mice, with greatest benefits in females.
New study reveals gut microbiome disruption in Alzheimer's patients and shows 12-week probiotic treatment reduces inflammation.
Home sleep monitoring reveals reduced REM sleep and total sleep time increase psychosis risk in Parkinson's patients.
New review reveals how gum disease and tooth loss worsen Alzheimer's while cognitive decline destroys oral health in vicious cycle.
New review reveals how gut microbiome disruption triggers neuroinflammation and accelerates Alzheimer's disease progression.
Comprehensive review reveals how gut microbiome imbalances contribute to brain disorders and identifies promising intervention strategies.
Multiomics study reveals gut microbiome shifts and inflammation markers detectable in earliest stages of cognitive decline.